Scinovex
articleTop 1% cited

MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTS

Transplantation · 1997 · Vol. 63(1) · pp. 39–47

Abstract

MMF proved superior to AZA as a posttransplant immunosuppressant in conjunction with cyclosporine and corticosteroids. MMF-treated groups showed reduced incidence and severity of rejection episodes, similar graft survival, and better graft function over 12 months.

Renal Transplantation Outcomes and TreatmentsOrgan Transplantation Techniques and OutcomesNeurological Complications and SyndromesMedicineAzathioprineRenal functionTransplantationClinical endpointGastroenterologyMycophenolateInternal medicineMycophenolic acidUrology

MeSH terms

AdultDouble-Blind MethodFemaleGraft RejectionHumansImmunosuppressive AgentsKidneyMaleMiddle AgedMycophenolic AcidTransplantation, HomologousKidney TransplantationCyclosporine
Citations
582
FWCI
29.49
field-weighted impact
References
16
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.